Agenzia Italiana del Farmaco
Home
The Italian Medicines Agency has published the seventh Pharmacovigilance Report on COVID-19 Vaccines. The data collected and analysed concern the reports of suspected adverse reactions registered in the National Pharmacovigilance Network between 27 December 2020 and 26 July 2021 for the four vaccines in use in the current vaccination campaign.
AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.
AIFA makes available, to healthcare professionals, a list of class A and H medicinal products dispensed by the National Health Service, sorted by active ingredient and trade name.
The 2020 National Report on medicines use in Italy, prepared by AIFA’s Medicines Utilisation Monitoring Centre (OsMed), was launched
Medicines alerts
AIFA Focus
"Do you want to know more about COVID-19 vaccines?"
26 July
10:30 - 12:00
07 September
da definire
15 September
da definire
Competitions
